Krečak, I., Bačić, J. A., Šimunić, N., Bušac, V., Pivac, Lj., Čubrić, E. ... Lucijanić, M. (2024). No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study. Heliyon, 10. (12). doi: 10.1016/j.heliyon.2024.e32827
Krečak, Ivan, et al. "No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study." Heliyon, vol. 10, no. 12, 2024. https://doi.org/10.1016/j.heliyon.2024.e32827
Krečak, Ivan, Josipa Antonija Bačić, Nevena Šimunić, Vesna Bušac, Ljerka Pivac, Eva Čubrić, Marko Skelin and Marko Lucijanić. "No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study." Heliyon 10, no. 12 (2024). https://doi.org/10.1016/j.heliyon.2024.e32827
Krečak, I., et al. (2024) 'No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study', Heliyon, 10(12). doi: 10.1016/j.heliyon.2024.e32827
Krečak I, Bačić JA, Šimunić N, Bušac V, Pivac Lj, Čubrić E, and sur.. No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study. Heliyon [Internet]. 2024 June 11 [cited 2024 December 03];10(12). doi: 10.1016/j.heliyon.2024.e32827
I. Krečak, et al., "No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study", Heliyon, vol. 10, no. 12, June 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:314923. [Accessed: 03 December 2024]